CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,079,000 | +11.4% | 286,334 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,867,000 | +18.8% | 287,248 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,571,000 | +51.3% | 287,797 | +29.7% | 0.00% | +100.0% |
| Q1 2016 | $1,038,000 | -4.1% | 221,901 | +2.1% | 0.00% | 0.0% |
| Q4 2015 | $1,082,000 | +33.6% | 217,369 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $810,000 | -38.8% | 215,377 | -2.2% | 0.00% | -50.0% |
| Q2 2015 | $1,323,000 | +49.8% | 220,166 | +39.7% | 0.00% | +100.0% |
| Q1 2015 | $883,000 | +89.5% | 157,602 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $466,000 | +11.5% | 155,218 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $418,000 | -5.4% | 155,954 | -1.3% | 0.00% | 0.0% |
| Q2 2014 | $442,000 | -31.5% | 158,013 | +6.8% | 0.00% | 0.0% |
| Q1 2014 | $645,000 | +37.5% | 147,964 | +1.3% | 0.00% | 0.0% |
| Q4 2013 | $469,000 | +98.7% | 146,017 | -1.5% | 0.00% | – |
| Q3 2013 | $236,000 | +0.4% | 148,186 | +9.0% | 0.00% | – |
| Q2 2013 | $235,000 | – | 135,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
| Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
| Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
| TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
| S&T BANK/PA | 334,252 | $9,107 | 1.76% |
| Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
| Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
| FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
| Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
| Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |